Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Change in Inventory of $2000.0 for Q4 2016, up 101.13% year-over-year from $994.38 in Q1 2016, and up 101.32% quarter-over-quarter from -$151000.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Change in Inventory history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2016.
- In Q4 2016, Change in Inventory rose 101.13% year-over-year to $2000.0; the TTM figure through Dec 2016 stood at -$123000.0 (down 1637.5% YoY), while the FY2016 annual figure was -$123000.0, down 1637.5% from the prior year.
- Change in Inventory for Q4 2016 stood at $2000.0, up from -$151000.0 in the prior quarter.
- The five-year high for Change in Inventory was $206000.0 in Q2 2015, with the low at -$232000.0 in Q1 2014.
- The 4-year median for Change in Inventory is $20500.0 (2014), against an average of -$1968.6.
- Peak annual rise in Change in Inventory reached 202.94% in 2015, while the deepest fall reached 541.03% in 2015.
- Viridian Therapeutics, Inc.\DE's Change in Inventory stood at $147854.0 in 2013, then tumbled by 135.85% to -$53000.0 in 2014, then plunged by 233.96% to -$177000.0 in 2015, then soared by 101.13% to $2000.0 in 2016.
- Business Quant data shows VRDN's Change in Inventory at $2000.0 in Q4 2016, -$151000.0 in Q3 2016, and -$56000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | -151,000.00 |
| Sep 30, 2016 | -151,000.00 |
| Jun 30, 2016 | -56,000.00 |
| Jun 30, 2016 | -56,000.00 |
| Mar 31, 2016 | 82,000.00 |
| Mar 31, 2016 | 82,000.00 |
| Dec 31, 2015 | -177,000.00 |
| Dec 31, 2015 | -177,000.00 |
| Sep 30, 2015 | -172,000.00 |
| Sep 30, 2015 | -172,000.00 |
| Jun 30, 2015 | 206,000.00 |
| Jun 30, 2015 | 206,000.00 |
| Mar 31, 2015 | 151,000.00 |
| Mar 31, 2015 | 151,000.00 |
| Dec 31, 2014 | -53,000.00 |
| Dec 31, 2014 | -53,000.00 |
| Sep 30, 2014 | 39,000.00 |
| Sep 30, 2014 | 39,000.00 |